Interestingly, the expression of FGF2 in HUVEC co-cultured with prostate cancer cells following docetaxel treatment (10nM for 48h) did not change compared with that in HUVEC co-cultured with prostate cancer cells without docetaxel treatment measured by qPCR (Figure S2A, S2B). This evidence concerns the gene FGF2 and prostate carcinoma.